The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

被引：0

作者：

Zohreh Safipour

Rogier van der Zanden

Joop van den Bergh

Paddy Janssen

Peter Vestergaard

Frank de Vries

Johanna H. M. Driessen

机构：

[1] Curaçao Medical Centre,Department of Clinical Pharmacy

[2] Maastricht University Medical Centre,Department of Clinical Pharmacy

[3] Maastricht University Medical Centre,Department of Internal Medicine

[4] Hasselt University,Faculty of Medicine and Life Science

[5] Viecuri Medical Centre,Department of Internal Medicine

[6] Viecuri Medical Centre,Department of Clinical Pharmacy

[7] Aalborg University Hospital,Departments of Clinical Medicines and Endocrinology

[8] Steno Diabetes Center North Jutland,MRC Lifecourse Epidemiology Unit

[9] Southampton General Hospital,Division of Pharmacoepidemiology and Clinical Pharmacology

[10] Utrecht Institute of Pharmaceutical Sciences,NUTRIM

[11] Cardiovascular Research Institute Maastricht (CARIM),School for Nutrition and Translational Research in Metabolism

[12] Maastricht University,undefined

来源：

Osteoporosis International | 2022年 / 33卷

关键词：

Glucocorticoids; Fracture; Bone; Myasthenia gravis; Case–control study;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：649 / 658

页数：9

共 50 条

[21] Effects of alendronate and alfacalcidol on bone in patients with myasthenia gravis initiating glucocorticoids treatment
Lv, Fang
Guan, Yuzhou
Ma, Doudou
Xu, Xiaojie
Song, Yuwen
Li, Lujiao
Jiang, Yan
Wang, Ou
Xia, Weibo
Xing, Xiaoping
Li, Mei
CLINICAL ENDOCRINOLOGY, 2018, 88 (03) : 380 - 387
[22] The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population -Based Cohort Study
Abtahi, Shahab
Burden, Andrea M.
Geusens, Piet
van den Bergh, Joop P.
van Staa, Tjeerd
de Vries, Frank
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (06) : 811 - 816
[23] Risk of fracture in patients using high-dose intermittent oral glucocorticoids
De Vries, F
Bracke, MSGM
Leufkens, HGM
Lammers, JWJ
Cooper, C
Van Staa, T
BONE, 2005, 36 : S126 - S127
[24] FRAXA® probabilities and risk of major osteoporotic fracture in France
Couris, C. M.
Chapurlat, R. D.
Kanis, J. A.
Johansson, H.
Burlet, N.
Delmas, P. D.
Schott, A. M.
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (09) : 2321 - 2327
[25] FRAX® probabilities and risk of major osteoporotic fracture in France
C. M. Couris
R. D. Chapurlat
J. A. Kanis
H. Johansson
N. Burlet
P. D. Delmas
A. M. Schott
Osteoporosis International, 2012, 23 : 2321 - 2327
[26] IMMINENT RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER FRACTURE (REYKJAVIK STUDY)
Harvey, N. C.
Johansson, H.
Siggeirsdottir, K.
Oden, A.
Gudnason, V.
McCloskey, E.
Sigurdsson, G.
Kanis, J. A.
OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S59 - S59
[27] Use of teriparatide in osteoporotic fracture patients
Collinge, Cory
Favela, Juan
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2016, 47 : S36 - S38
[28] Risk of diabetes mellitus among patients with myasthenia gravis
Yeh, J. -H.
Chen, H. -J.
Lin, C. -C.
Chen, Y. -K.
Chiu, H. -C.
Kao, C. -H.
ACTA NEUROLOGICA SCANDINAVICA, 2015, 132 (02): : 132 - 138
[29] Risk factors for tumor occurrence in patients with myasthenia gravis
Citterio, Antonietta
Beghi, Ettore
Millul, Andrea
Evoli, Amelia
Mantegazza, Renato
Antozzi, Carlo
Baggi, Fulvio
Cornelio, Ferdinando
Durelli, Luca
Clerico, Marinella
Piccolo, Giovanni
Cosi, Vittorio
JOURNAL OF NEUROLOGY, 2009, 256 (08) : 1221 - 1227
[30] Risk factors for tumor occurrence in patients with myasthenia gravis
Antonietta Citterio
Ettore Beghi
Andrea Millul
Amelia Evoli
Renato Mantegazza
Carlo Antozzi
Fulvio Baggi
Ferdinando Cornelio
Luca Durelli
Marinella Clerico
Giovanni Piccolo
Vittorio Cosi
Journal of Neurology, 2009, 256 : 1221 - 1227

← 1 2 3 4 5 →